Clinical Trial Update: An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of Yondelis (trabectedin) in patients with advanced relapsed ovarian cancer. The study is completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Yondelis (trabectedin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-08-23